210 likes | 428 Views
iGATE RESEARCH report entitled “Global - Adult Vaccines Market & Company Analysis to 2020” is a 232 page report with 142 Figures and 8 Tables. This report studies in detail the adult vaccines market disease wise, company wise sales analysis and strategic alliances, mergers and acquisitions along with growth drivers and hindrances for the vaccines market landscape. Click here to view the complete report: http://www.igateresearch.com/ProductDetail.php?pd_name=Global - Adult Vaccines Market Analysis to 2020 Contact US iGATE Research PVT LTD Ravi Sinha Sales Manager Marketing and Sales Divison Email: ravi.sinha@igateresearch.com Contact: 91-858-684-0791, 91-706-527-9335 (INDIA) Web: www.igateresearch.com
E N D
Table of Contents Executive Summary 2. Global- Adult Vaccines Analysis and Forecast (2007 - 2020) 2.1 Global Adult Vaccines Market and Forecast 2.2 Global Adult Vaccines - Number of Adults Vaccinated and Forecast 3. Global Adult Vaccine Market Share Analysis and Forecast (2010 - 2020) 3.1 Global Adult Vaccines - Disease Wise Adults Vaccinated Share and Forecast 3.2 Global Adult Vaccines - Disease Wise Market Share and Forecast 3.3 Global Adult Vaccines - Company Wise Market Share and Forecast
Continue (www.igateresearch.com) • 3.4 Companies Adult Vaccines - Disease Wise Sales Share and Forecast • 3.4.1 GlaxoSmithKline (GSK) - Adult Vaccines Sales Share and Forecast • 3.4.2 Sanofi Pasteur - Adult Vaccines Sales Share and Forecast • 3.4.3 Merck - Adult Vaccines Sales Share and Forecast • 3.4.4 Novartis - Adult Vaccines Sales Share and Forecast
Continue (www.igateresearch.com) • 3.5 Adult Vaccine Disease Wise Market - Company Share and Forecast • 3.5.1 Influenza Adult Vaccines - Company Market Share and Forecast • 3.5.2 Cervical Cancer/HPV Adult Vaccines - Company Market Share and Forecast • 3.5.3 Hepatitis Adult Vaccines - Company Market Share and Forecast • 3.5.4 Pneumococcal Adult Vaccines - Company Market Share and Forecast • 3.5.5 Meningococcal Adult Vaccines - Company Market Share and Forecast • 3.5.6 DTP (Diphtheria, Tetanus, Pertussis) Adult Vaccines - Company Market Share and Forecast • 3.6 Global Adult Vaccines Market - Region Wise Share and Forecast
4. Global Adult Vaccine Market - Disease Wise Analysis • 4.1 Influenza - Adult Vaccine Analysis and Forecast (2007 - 2020) • 4.1.1 Influenza - Adult Vaccine Market and Forecast • 4.1.2 Influenza - Number of Adults Vaccinated and Forecast • 4.1.3 Influenza - Number of Vaccines Doses and Forecast • 4.2 Cervical Cancer/ HPV - Adult Vaccine Analysis and Forecast (2007 - 2020) • 4.2.1 Cervical Cancer/ HPV - Adult Vaccine Market and Forecast • 4.2.2 Cervical Cancer/ HPV - Number of Adults Vaccinated and Forecast • 4.2.3 Cervical Cancer/ HPV - Number of Vaccines Doses and Forecast
Continue (www.igateresearch.com) • 4.3 Zoster Shingles - Adult Vaccine Analysis and Forecast (2007 - 2020) • 4.3.1 Zoster Shingles - Adult Vaccine Market and Forecast • 4.3.2 Zoster Shingles - Number of Adults Vaccinated and Forecast • 4.3.3 Zoster Shingles - Number of Vaccines Doses and Forecast • 4.4 Pneumococcal - Adult Vaccine Analysis and Forecast (2010 - 2020) • 4.4.1 Pneumococcal - Adult Vaccine Market and Forecast • 4.4.2 Pneumococcal - Number of Adults Vaccinated and Forecast • 4.4.3 Pneumococcal - Number of Vaccines Doses and Forecast
Continue (www.igateresearch.com) • 4.5 Meningococcal - Adult Vaccine Analysis and Forecast (2010 - 2020) • 4.5.1 Meningococcal - Adult Vaccine Market and Forecast • 4.5.2 Meningococcal - Number of Adults Vaccinated and Forecast • 4.5.3 Meningococcal - Number of Vaccines Doses and Forecast • 4.6 Measles, Mumps, Rubella and Varicella (MMRV) - Adult Vaccine Analysis and Forecast (2010 - 2020) • 4.6.1 MMRV - Adult Vaccine Market and Forecast • 4.6.2 MMRV - Number of Adults Vaccinated and Forecast • 4.6.3 MMRV- Number of Vaccines Doses and Forecast
Continue (www.igateresearch.com) • 4.7 Hepatitis - Adult Vaccine Analysis and Forecast (2007 - 2020) • 4.7.1 Hepatitis - Adult Vaccine Market and Forecast • 4.7.2 Hepatitis - Number of Adults Vaccinated and Forecast • 4.7.3 Hepatitis - Number of Vaccines Doses and Forecast • 4.8 DTP - Adult Vaccine Analysis and Forecast (2007 - 2020) • 4.8.1 DTP - Adult Vaccine Market and Forecast • 4.8.2 DTP - Number of Adults Vaccinated and Forecast • 4.8.3 DTP - Number of Vaccines Doses and Forecast • 4.9 Travel and Miscellaneous - Adult Vaccine Analysis and Forecast (2007 - 2020)
5. Global Adult Vaccine Market - Company Analysis & Strategic Alliances • 5.1 GlaxoSmithKline • 5.1.1 GlaxoSmithKline (GSK) - Adult Vaccine Sales and Forecast • 5.1.2 Strategic Alliances of GlaxoSmithKline (GSK) • 5.2 Sanofi Pasteur • 5.2.1 Sanofi Pasteur Vaccines Sales and Forecast • 5.2.2 Strategic Alliances of Sanofi Pasteur • 5.3 Merck • 5.3.1 Merck Vaccines Sales and Forecast • 5.3.2 Strategic Alliances of Merck
Continue (www.igateresearch.com) • 5.4 Novartis • 5.4.1 Novartis Vaccines Sales and Forecast • 5.4.2 Strategic Alliances of Novartis • 5.5 Pfizer • 5.5.1 Pfizer Adult Vaccines Sales and Forecast • 5.5.2 Strategic Alliances of Pfizer • 5.6 Other Companies Sales and Forecast
6. Global Adult Vaccine - Disease Wise Company Sales and Forecast (2007 - 2020) • 6.1 GlaxoSmithKline (GSK) - Adult Vaccines Sales and Forecast • 6.1.1 GlaxoSmithKline (GSK) - Influenza Adult Vaccines Sales and Forecast • 6.1.2 GlaxoSmithKline (GSK) - Cervical Cancer/HPV Adult Vaccines Sales and Forecast • 6.1.3 GlaxoSmithKline (GSK) - Hepatitis Adult Vaccines Sales and Forecast • 6.1.4 GlaxoSmithKline (GSK) - DTP Adult Vaccines Sales and Forecast
Continue (www.igateresearch.com) • 6.2 Sanofi Pasteur - Adult Vaccines Sales and Forecast • 6.2.1 Sanofi Pasteur - Influenza Adult Vaccines Sales and Forecast • 6.2.2 Sanofi Pasteur - DTP Adult Vaccines Sales and Forecast • 6.2.3 Sanofi Pasteur - Meningococcal Adult Vaccines Sales and Forecast
Continue (www.igateresearch.com) • 6.3 Merck - Adult Vaccines Sales and Forecast • 6.3.1 Merck/CSL - Influenza Adult Vaccines Sales and Forecast • 6.3.2 Merck - Cervical Cancer/HPV Adult Vaccines Sales and Forecast • 6.3.3 Merck - Zoster Shingles Adult Vaccines Sales and Forecast • 6.3.4 Merck - Pneumococcal Adult Vaccines Sales and Forecast • 6.3.5 Merck - MMRV Adult Vaccines Sales and Forecast • 6.3.6 Merck - Hepatitis Adult Vaccines Sales and Forecast
Continue (www.igateresearch.com) • 6.4 Novartis - Adult Vaccines Sales and Forecast • 6.4.1 Novartis - Influenza Adult Vaccines Sales and Forecast • 6.4.2 Novartis - Meningococcal Adult Vaccines Sales and Forecast • 6.5 Pfizer - Adult Vaccines Sales and Forecast • 6.5.1 Pfizer - Pneumococcal Adult Vaccines Sales and Forecast
7. Global Adult Vaccine Market - Regional Distribution (2011 - 2020) • 7.1 United States - Adult Vaccine Market and Forecast • 7.2 North America/Caribbean - Adult Vaccine Market and Forecast • 7.3 South America - Adult Vaccine Market and Forecast • 7.4 Europe - Adult Vaccine Market and Forecast • 7.5 Japan - Adult Vaccine Market and Forecast • 7.6 India - Adult Vaccine Market and Forecast • 7.7 China - Adult Vaccine Market and Forecast • 7.8 Rest of the World (ROW) - Adult Vaccine Market and Forecast • 8. Major Vaccine Related Acquisitions (2005-2015)
9. Adult Vaccines Market - Driving Factors • 9.1 GAVI Model Fuelling Vaccine Manufacturers • 9.1.1 The Partnership Model • 9.1.2 The Business Model • 9.2 Global Immunization Vision and Strategy (GIVS) • 9.3 Growing Vaccine Availability in United States • 9.4 The Vaccine Injury Compensation Program • 9.5 The Vaccine Safety Data link Project • 9.6 Transformation of Vaccine Technologies • 9.7 Global Vaccine Action Plan by WHO (2011 - 2020) • 9.8 Continuous Focus on Effective Communication Strategies
10. Adult Vaccines Market - Challenges • 10.1 Hurdles to Optimal use of Licensed Vaccines • 10.2 Shortening the Timeline for Vaccine Development • 10.3 Complexity of Vaccine Development and Approval System Thwarts Product Development • 10.4 Refusal/Resistance to Vaccination • 10.5 Vaccine Adverse Event Reporting System • 10.6 Vaccine Shortages and Delays • 10.7 Obstacles in Vaccine Research and Development • 10.8 Barriers to New Entrants in the Vaccines Market
Source of Information iGATERESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.
Published By iGATE RESEARCH Phone: +91-858-684-0791 (India) +91-706-527-9335 (India) Email: info@igateresearch.com Internet:www.igateresearch.com
Format • Report Title: Global - Adult Vaccines Market & Company Analysis to 2020 • To Order the Report Visit: • http://www.igateresearch.com/ProductDetail.php?pd_name=Global%20-%20Adult%20Vaccines%20Market%20%20Analysis%20to%202020
Order the Report • iGATE RESEARCH PVT. LTD. • Web: www.igateresearch.com • To order the Report: • E-Mail: info@igateresearch.com • Contact No. : +91-858-684-0791, +91-706-527-9335 (INDIA) • For Report Related Query: • E-Mail: info@igateresearch.com • Contact No. : +91-858-684-0791, +91-706-527-9335 (INDIA)